英文别名 |
nedisertib;peposertib;M3814;MSC2490484A;GN429E725A;(S)-(2-chloro-4-fluoro-5-(7-morpholinoquinazolin-4-yl)phenyl)(6-methoxypyridazin-3-yl)methanol;(S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol;Nedisertib [INN];nedisertib (deleted INN);GTPL9766;BDBM315715;MSC 2490484A;NSC802822;NSC816960;US10172859, Example 136;MSC 2490484A [W;HY-101570;PEPOSERTIB [WHO-DD];example 136 [WO2014183850];PEPOSERTIB [INN];M-3814(nedisertib);CS-0021723;DA-65178;M 3814;peposertibum;(~{S})-[2-chloranyl-4-fluoranyl-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol;3-Pyridazinemethanol, alpha-(2-chloro-4-fluoro-5-(7-(4-morpholinyl)-4-quinazolinyl)phenyl)-6-methoxy-, (alphaS)-;EX-A1679;3-PYRIDAZINEMETHANOL, .ALPHA.-(2-CHLORO-4-FLUORO-5-(7-(4-MORPHOLINYL)-4-QUINAZOLINYL)PHENYL)-6-METHOXY-, (.ALPHA.S)-;UNII-GN429E725A;(S)-(2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl)-(6-methoxypyridazin-3-yl)methanol;NSC-816960;SCHEMBL16235559;MSC 2490484A [WHO-DD];CHEMBL4297629;1637542-33-6;1IX;M-3814;NSC-802822;example 136 (WO2014183850);MSC-2490484A;TS-10640 |